These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17474891)

  • 21. Multiplex PCR-RFLP assay for detection of factor V Leiden and prothrombin G20210A.
    Baris I; Koksal V; Etlik O
    Genet Test; 2004; 8(4):381-3. PubMed ID: 15684866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon.
    Bouaziz-Borgi L; Almawi WY; Mtiraoui N; Nsiri B; Keleshian SH; Kreidy R; Louzir B; Hezard N; Mahjoub T
    Am J Hematol; 2006 Aug; 81(8):641-3. PubMed ID: 16823828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thrombosis with both heterozygous factor V Leiden (R507Q) and factor II (G20210A) mutations.
    Bhaijee F; Jordan B; Pepper DJ; Leacock R; Rock WA
    Clin Lab Sci; 2012; 25(4):199-205. PubMed ID: 23330508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double fluorescent-amplification refractory mutation detection (dF-ARMS) of the factor V Leiden and prothrombin mutations.
    Maher C; Crowley D; Cullen C; Wall C; Royston D; Fanning S
    Thromb Haemost; 1999 Jan; 81(1):76-80. PubMed ID: 9974379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
    Yilmazer M; Kurtay G; Sonmezer M; Akar N
    Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prothrombotic gene mutations and Crohn's disease; is there any association?
    Over-Hamzaoglu H; Abaci N; Türe F; Alkim C; Tezel A; Avsar E; Tözün N
    Hepatogastroenterology; 2005; 52(65):1467-9. PubMed ID: 16201098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
    Kyrle PA; Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Melichart M; Traxler G; Weltermann A; Speiser W; Lechner K
    Thromb Haemost; 1997 May; 77(5):829-33. PubMed ID: 9184387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A whole-blood homogeneous assay for the multiplex detection of the factor V G1691A and the prothrombin G20210A mutations.
    Hobson-Peters J; Toye P
    Mol Cell Probes; 2005 Aug; 19(4):290-7. PubMed ID: 16006096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplex PCR for one-step determination of the G20210A variation and the factor V Leiden mutation by denaturing gradient gel electrophoresis (DGGE).
    Patri S; Salmeron S; Caillon M; Kitzis A; Chomel JC
    Thromb Haemost; 1999 Feb; 81(2):313-4. PubMed ID: 10064013
    [No Abstract]   [Full Text] [Related]  

  • 32. Four-color multiplex 5' nuclease assay for the simultaneous detection of the factor V Leiden and the prothrombin G20210A mutations.
    Ugozzoli LA; Hamby K
    Mol Cell Probes; 2004 Jun; 18(3):161-6. PubMed ID: 15135449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated, simultaneous detection of the factor V Leiden and prothrombin (G20210A) variants using multiplex PCR and a line probe assay.
    Leyte A; Smits PH; van Straalen JP; van Doorn LJ; Quint WG
    Thromb Haemost; 2000 Feb; 83(2):354-5. PubMed ID: 10739403
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
    Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S; Keskin N; Keskin A; Atalay E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism.
    Bonduel M; Sciuccati G; Hepner M; Pieroni G; Torres AF; Mardaraz C; Frontroth JP
    Am J Hematol; 2003 Jun; 73(2):81-6. PubMed ID: 12749008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A very rapid multiplex polymerase chain reaction for simultaneous detection of factor V Leiden and G20210A prothrombin mutation.
    Corrêa MF; Rezende SM
    Clin Lab Haematol; 2004 Jun; 26(3):239-40. PubMed ID: 15163325
    [No Abstract]   [Full Text] [Related]  

  • 39. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
    Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
    Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.